Guidelines for The Classification of Deficiencies Observed During Inspection of Drug Manufacturers

Guidelines for The Classification of Deficiencies Observed During Inspection of Drug Manufacturers

FDA CIRCULAR NO. 2019-003 14 FEB 2019 Subject:  GUIDELINES FOR THE CLASSIFICATION OF DEFICIENCIES OBSERVED DURING INSPECTION OF DRUG MANUFACTURE  ...
Read More
Authority for the officers of Drug Good Manufacturing Practice (GMP) Inspectorate Task Force to conduct inspection and post marketing surveillance in accordance with Republic Act 9711, even beyond office hours, as the need arises in Luzon, Visayas and Mindanao from January to December 2019
Notice on the Adoption of the PIC/S Guide to GMP

Notice on the Adoption of the PIC/S Guide to GMP

Administrative Order (AO) No. 2012-008, or the rules on the “Adoption and Implementation of the Pharmaceutical Inspection Cooperation Scheme (PIC/S)...
Read More
Creation of Technical Working Group for the Effective Implementation of the PICS/GMP Guide for Medicinal Products

Creation of Technical Working Group for the Effective Implementation of the PICS/GMP Guide for Medicinal Products

FDA MEMORANDUM CIRCULAR NO. 2018-003 13 July 2018 TO : All Drug Establishments and concerned Offices, Officers, and Personnel within...
Read More
Authority of FDA Inspectors

Authority of FDA Inspectors

FDA Circular 2012-011   05 September 2012   TO: ALL FDA Inspectors and Drug Establishments   SUBJECT: Authority of FDA...
Read More